Cardio Diagnostics Holdings is trading 5% up at $2.08, following a broader risk-on market move after August inflation data matched expectations.

  • Major U.S. indexes are also higher, supporting a global-market explanation for the gain.
  • No company-specific press release was listed for September 10 or September 11, 2026; the latest listed announcement was dated August 26, so no direct corporate catalyst was identified.